Andrzej Adam Mackiewicz
338 works · 25,832 citations · h-index 53
Top works
- Comprehensive molecular characterization of gastric adenocarcinoma
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- Genomic Classification of Cutaneous Melanoma
- Principal components analysis (PCA)
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins
- The soluble interleukin‐6 receptor is generated by shedding
- Acute Phase Proteins Molecular Biology, Biochemistry, and Clinical Applications
- Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
- Microheterogeneity of Alpha‐fetoprotein in Patient Serum as Demonstrated by Lectin Affino‐electrophoresis
- Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
- A high proportion of founder BRCA1 mutations in Polish breast cancer families
- Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials
- 3301 Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (Vem) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma
- Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
- Characterization of HPV and host genome interactions in primary head and neck cancers
- Microheterogeneity forms of alpha1-acid glycoprotein as indicators of rheumatoid arthritis activity
- Interleukin‐6‐Type Cytokine‐induced Changes in Acute Phase Protein Glycosylationaa
- Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
- Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial